True Health Diagnostics

True Health Diagnostics is a privately held health services company operated by True Health Group, LLC, an organization of healthcare entities providing medical services. Headquartered in Frisco, Texas, True Health specializes in earlier-stage prevention and diagnosis of chronic disease, including cardiovascular disease, diabetes, cancer, genetic disorders and a range of metabolic conditions.[1][2] The company's laboratory can detect conditions not apparent through customary diagnostic tests.[3] It provides healthcare organizations with comprehensive testing for early detection of chronic diseases.[4] The company maintains CLIA-certified, CAP-accredited laboratory facilities in the North Texas Enterprise Center in Frisco and in the Virginia BioTechnology Research Park in Richmond, Virginia.[5][6][7][8]

History

True Health Diagnostics was founded by Chris Grottenthaler in March 2014 as a specialty lab that would specialize in early stage identification of diseases.[7] The company began operations in October 2014.

True Health purchased the assets of Health Diagnostic Laboratory, Inc. at a court-supervised auction, in September 2015 for $37.1 million.[9][10] The sale was approved by Judge Kevin Huennekens of the United States Bankruptcy Court for the Eastern District of Virginia the same month.[1] True Health did not assume HDL’s liabilities as part of the sale.[11] True Health Diagnostics voluntarily assumed a corporate integrity agreement when it acquired HDL’s assets which requires an independent review of its compliance program and a comprehensive report to the Office of Inspector General.[12][13]

Products

True Health provides chronic disease detection and management to medical professionals and patients with cardiovascular illness, cancer, diabetes and others. The laboratory uses biomarkers to assess a patient’s health and do more than 100 assays for chronic diseases.[14][15] Once a diagnosis is made, the company also provides services including online disease prevention programs, and wellness education programs and nutrition plans.[3]

Research

In 2016, Harvard Medical School completed a study of omega-3 fatty acids on heart function in patients who have suffered a heart attack, which was published in the journal Circulation, a publication of the American Heart Association, in 2016.[16] True Health Diagnostics provided researchers with proprietary testing services that underpinned the study.[17]

References

  1. 1 2 "U. S. bankruptcy judge approves bid by a Texas startup to buy HDL for $37.1 million · Industries | Virginia Business". www.virginiabusiness.com. Retrieved 2016-10-18.
  2. "Biotech Eight". Virginia Biotechnology Research Park. Retrieved 2016-10-18.
  3. 1 2 "Dallas News: Breaking News for DFW, Texas, World". Dallas News. Retrieved 2016-10-18.
  4. "Sponsors". www.beckershospitalreview.com. Retrieved 2016-10-18.
  5. "NTEC Member Companies - NTEC | North Texas Enterprise Center | Frisco, TX". NTEC | North Texas Enterprise Center | Frisco, TX. Retrieved 2016-10-18.
  6. "ABOUT". Virginia Biotechnology Research Park. Retrieved 2016-10-18.
  7. 1 2 "Q&A: Picking up the pieces of HDL". Richmond BizSense. 2015-11-02. Retrieved 2016-10-18.
  8. "Accredited Laboratory Directory - College of American Pathologists". www.cap.org. Retrieved 2016-11-10.
  9. "HDL buyer to dissolve brand". Richmond BizSense. 2015-09-30. Retrieved 2016-10-18.
  10. "True Health Diagnostics Prevails in Winning Bid to Acquire Health Diagnostics Laboratory | Business Wire". www.businesswire.com. Retrieved 2016-10-18.
  11. "Judge approves $37M sale of HDL". Richmond BizSense. 2015-09-17. Retrieved 2016-10-18.
  12. "Aetna Moves Closer to Recovering Money in Lab Billing Fraud". www.bna.com. Retrieved 2016-10-24.
  13. Newswire, PR (2016-08-25). "True Health Diagnostics Successfully Completes First Year Of Corporate Integrity Agreement". TheStreet. Retrieved 2016-10-24.
  14. "Provider Overview". True Health Diagnostics, LLC. Retrieved 2016-10-18.
  15. "Risk Identification". True Health Diagnostics, LLC. Retrieved 2016-10-18.
  16. Heydari, Bobak; Abdullah, Shuaib; Pottala, James V.; Shah, Ravi; Abbasi, Siddique; Mandry, Damien; Francis, Sanjeev A.; Lumish, Heidi; Ghoshhajra, Brian B. (2016-08-02). "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial InfarctionClinical Perspective". Circulation. 134 (5): 378–391. doi:10.1161/CIRCULATIONAHA.115.019949. ISSN 0009-7322. PMC 4973577Freely accessible. PMID 27482002.
  17. Diagnostics, True Health. "True Health Diagnostics' Proprietary Testing Underpins Harvard Study on Diet, Cardiac Function". www.prnewswire.com. Retrieved 2016-10-18.

External links

This article is issued from Wikipedia - version of the 11/10/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.